Cor Vasa 2007, 49(9):334-340 | DOI: 10.33678/cor.2007.116
Angina, its diagnosis and treatment.
- Interní-kardiologická klinika, Fakultní nemocnice Brno-Bohunice, Brno, Česká republika
Angina pectoris is a clinical entity, with its diagnosis based on the patient s self-reported history of pain. This is defined by its location, nature, duration, and relation to exertion. Typical angina is characterized by three basic features: 1. tight chest, 2. it is induced by exertion or stress, 3. it resolves quickly at rest or after the administration of rapid-onset nitrates. Potential or atypical angina presents with only two of these featur and non-specific or anginal pain with only one. Non-invasive diagnosis of angina is based on a thorough assessment of the patient s symptoms and interpretation of the results of diagnostic procedures. The paper discusses in detail the value of non-invasive diagnostic methods and coronary angiography. Attention is also given to the long-term prognosis of patients and risk stratification. Patients with angina and an annual risk of death > 2%, as established using a validated prediction model, are considered high-risk individuals. Cardiovascular mortality rates below 1% and in 1-2% range are associated with low and medium risks, respectively. The key markers for risk stratification include the clinical finding, response to exercise, assessment of left ventricular function, and extent of coronary involvement. Antianginal drug therapy can be divided into modalities improving patients prognosis and those relieving symptoms and ischemia. Both therapeutic approaches are reviewed in detail including novel strategies and recommendations for rational drug therapy.
Keywords: Angina; Coronary heart disease; Rational drug therapy
Published: September 1, 2007 Show citation
References
- Guidelines on the management of stable angina pectoris: executive summary. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-81.
- Diamond AG. A clinically relevant classification of chest pain discomfort. J Am Coll Cardiol 1983;1:574-5.
Go to original source...
Go to PubMed...
- Campeau L. Letter: grading of angina pectoris. Circulation 1976;54:522-3.
Go to original source...
- Chaloupka V. Zátěžové testy v kardiologii. Zátěžová elektrokardiografie. Cor Vasa 2000;42:K43-K49.
- Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002;106:2351-7.
Go to original source...
Go to PubMed...
- Ashley EA, Myers J, Froelicher V. Exercise testing in clinical medicine. Lancet 2000;356:1592-7.
Go to original source...
Go to PubMed...
- Chen G, Redberg RF. Noninvasive diagnostc testing of coronary artery disease in women. Cardiol Rev 2000; 8:354-60.
Go to original source...
Go to PubMed...
- Chaloupka V, Elbl L, Nehyba S, et al. Exercise intensity prescription after myocardial infarction in patients treated with beta-blocker. J Cardiopulm Rehab 2005; 25:361-5.
Go to original source...
Go to PubMed...
- Marwick HT. Current status of stress echocardiography for diagnosis and prognosis assessment of coronary artery disease. Coron Artery Dis 1998;9:411-26.
Go to original source...
Go to PubMed...
- De Backer, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-10.
Go to original source...
Go to PubMed...
- Conroy RM, Pyörälä K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE Project. Eur Heart J 2003;11:987-1003.
Go to original source...
Go to PubMed...
- Cífková R, Býma S, Češka R, a spol. Prevence kardiovaskulárních onemocnění v dospělém věku. Cor Vasa 2005;47 (Suppl):3-14.
- Braunwald E, Domanski MJ, Fowler SE, et al. Angiotenzin-converting enzyme inhibition in stable coronary artery disease. New Engl J Med 2004;351:2058-68.
Go to original source...
Go to PubMed...
- Heart Outcomes Prevention Evaluation Study Investigators. Effect of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;359:1269-75.
- Chaloupka V, Elbl L, Nehyba S, Tomášková I, Jedlička F. Vliv rehabilitačního programu na prognózu nemocných po infarktu myokardu. Cor Vasa 2004;46:29-35.
- Emond M, Mock MB, Davis KG, et al. Long term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1994;90: 2645-57.
Go to original source...
Go to PubMed...
- Diamond JA, Philips RA. Hypertensive heart disease. Hypertens Res 2005;28:191-202.
Go to original source...
Go to PubMed...
- Bory M, Pierron F, Panadiges D, et al. Coronary artery spasm in patients with normal or near normal coronary arteries. Long term folow-up of 277 patients. Eur Heart J 1996;17:1015-21.
Go to original source...
Go to PubMed...
- Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-71.
Go to original source...
- Fox KM, Thadani U, Ma PT, et al. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur Heart J 2003;24:2206-12.
Go to original source...
Go to PubMed...
- Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324:71-86.
Go to original source...
Go to PubMed...
- Chan FK, Chink JY, Wong VW, et al. Clopidogrel vs. and esomeprazole to prevent recurrent bleeding. New Engl J Med 2005;352:238-44.
Go to original source...
Go to PubMed...
- Balantine C. Evolving concepts and a new approach for management of hyperlipidemia. Eur Heart J 2002;4 (Suppl J):J1-J3.
Go to original source...
- Sudhop T, Lutjohann D, Kodal A, et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 2002;106:1943-8.
Go to original source...
- Olsson AG, Schwartz GG, Szarek M, et al. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Eur Heart J 2005;26:890-6.
Go to original source...
Go to PubMed...
- Freemantle N, Urdahl H, Eastaugh J, et al. What is the place of beta-blocade in patients who have experienced a myocardial infarction with preserved left ventricular function? Evidence and (miss)interpretation. Prog Cardiovasc Dis 2002;44:243-50.
Go to original source...
- Fox MK. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782-8.
Go to original source...
- Bultas J. Léčba anginy pectoris. Jak dnes, jak zítra? Medicína po promoci 2004;5:14-30.
- Manchanda SC, Krishnaswami S. Combination treatment with trimetazidine and diltiazem in stable angina pectoris. Heart 1997;78:353-7.
Go to original source...
Go to PubMed...
- Hradec J, Filipová J. TRIKET I a II (TRImetazidin v Kombinaci s Existující Terapií). Výsledky české a slovenské multicentrické studie u 320 nemocných se stabilní námahovou anginou pectoris. Cor Vasa 2001;43:436-42.
- Chaloupka V. Trimetazidin v léčbě stabilní anginy pectoris. TRIADA - (TRImetazidine in stable Angina twice Daily). Vnitř Lék 2006;52:609-14.
Go to PubMed...
- Bultas J. Ivabradin. Remedia 2006;16:463-73.
Go to original source...
- Hradec M. Kombinační léčba anginy pectoris. Remedia 2006;16:237-42.